Entera Bio ENTX
NASDAQ ENTX
$2.91 +0.00 (+0.00%)
As of: Oct 1, 2026 · 11:32 AM EDT

Entera Bio (ENTX) Change in Receivables (2021 - 2024)

Updated

Entera Bio (ENTX) posted Change in Receivables of -$126,000 for FY2025, compared with $126,000 in FY2024.

Analysis

Entera Bio (ENTX) Change in Receivables (2021 - 2024) Analysis & Trends

Since FY2018, Entera Bio has reported Change in Receivables for 8 years.

  • Annual Change in Receivables has run from a low of -$246,000 in FY2023 to a high of $126,000 in FY2024 over five years.
  • Business Quant data shows ENTX's Change in Receivables at $126,000 in FY2024, -$246,000 in FY2023, $63,000 in FY2022 and -$72,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Entera Bio 143.43 Mn 112.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -7,000.00
Sep 30, 2024 76,000.00
Jun 30, 2024 57,000.00
Sep 30, 2023 -29,000.00
Mar 31, 2023 -217,000.00
Dec 31, 2022 13,000.00
Sep 30, 2022 8,000.00
Jun 30, 2022 15,000.00
Mar 31, 2022 27,000.00
Dec 31, 2021 -69,000.00
Sep 30, 2021 136,000.00
Jun 30, 2021 101,000.00
Mar 31, 2021 -240,000.00
API Access

Entera Bio Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ENTX&period=max&api_key=YOUR_API_KEY